ELUT Valuation Metrics
FCF—
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
ELUT
Elutia Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Medical Devices
Aziyo Biologics Inc - Class A
Did you know?
Price sits at 26% of its 52-week range.
Current Price
$1.01
-0.98%Profile
Valuation (TTM)
Market Cap$43.13M
P/E0.81
EV—
P/B1.56
Shares Out42.70M
P/Sales2.28
Revenue$18.89M
EV/EBITDA0.31
Elutia Inc - Class A (ELUT) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →ELUT Valuation & Fair Value Analysis
Elutia Inc - Class A (ELUT) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is 0.81. Price-to-book ratio is 1.56. Price-to-sales ratio is 2.28. Enterprise value to EBITDA is 0.31. PEG ratio is -0.00.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Elutia Inc - Class A's intrinsic value.